Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
June 9, 2025
Burden of disease and unmet clinical needs in pediatric patients with asthma: real-world experience from the United States and five European countries
Wei-Han Cheng, Kinga Borsos, Zhixiao Wang, et al.
Advances in Therapy
|
June 7, 2023
Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study
Anthony Martinez, Wei-Han Cheng, Steven E Marx, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 26, 2026
Long-term efficacy of dupilumab versus tezepelumab in asthma: a matching-adjusted indirect comparison
Kenneth R Chapman, Nick Freemantle, Patricia Guyot, et al.
Cancer Medicine
|
August 12, 2023
Post-remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre- versus post-VIALE-A real-world experience from a predominantly US community setting
Pankit Vachhani, Esprit Ma, Tao Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 16, 2023
Early Real-World First-Line Treatment With Venetoclax Plus HMAs Versus HMA Monotherapy Among Patients With AML in a Predominately US Community Setting
Anda Gershon, Esprit Ma, Tao Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 23, 2023
Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs)
Amer M Zeidan, Elizabeth S Mearns, Carmen D Ng, et al.
ERJ Open Research
|
August 5, 2025
Real-world comparative effectiveness of biologic therapies in severe asthma: EU-ADVANTAGE
Giorgio Walter Canonica, Johann Christian Virchow, Arnaud Bourdin, et al.
Advances in Therapy
|
October 27, 2021
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019
Nancy Reau, Mark S Sulkowski, Emmanuel Thomas, et al.
Journal of Clinical Medicine
|
October 13, 2021
The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030
Marleen van Dijk, Sylvia M Brakenhoff, Cas J Isfordink, et al.
American Journal of Hematology
|
October 30, 2022
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes
Amer M Zeidan, Uma Borate, Daniel A Pollyea, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
June 9, 2025
Burden of disease and unmet clinical needs in pediatric patients with asthma: real-world experience from the United States and five European countries
Wei-Han Cheng, Kinga Borsos, Zhixiao Wang, et al.
Advances in Therapy
|
June 7, 2023
Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study
Anthony Martinez, Wei-Han Cheng, Steven E Marx, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 26, 2026
Long-term efficacy of dupilumab versus tezepelumab in asthma: a matching-adjusted indirect comparison
Kenneth R Chapman, Nick Freemantle, Patricia Guyot, et al.
Cancer Medicine
|
August 12, 2023
Post-remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre- versus post-VIALE-A real-world experience from a predominantly US community setting
Pankit Vachhani, Esprit Ma, Tao Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 16, 2023
Early Real-World First-Line Treatment With Venetoclax Plus HMAs Versus HMA Monotherapy Among Patients With AML in a Predominately US Community Setting
Anda Gershon, Esprit Ma, Tao Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 23, 2023
Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs)
Amer M Zeidan, Elizabeth S Mearns, Carmen D Ng, et al.
ERJ Open Research
|
August 5, 2025
Real-world comparative effectiveness of biologic therapies in severe asthma: EU-ADVANTAGE
Giorgio Walter Canonica, Johann Christian Virchow, Arnaud Bourdin, et al.
Advances in Therapy
|
October 27, 2021
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019
Nancy Reau, Mark S Sulkowski, Emmanuel Thomas, et al.
Journal of Clinical Medicine
|
October 13, 2021
The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030
Marleen van Dijk, Sylvia M Brakenhoff, Cas J Isfordink, et al.
American Journal of Hematology
|
October 30, 2022
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes
Amer M Zeidan, Uma Borate, Daniel A Pollyea, et al.
Page
of 3